Latin America Immunoglobulin Market 2022-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	105 Pages	Triton Market Research	July, 2022	TRTN17307653

Best Price Guarantee
Price	from $1,500
Length	105 Pages
Publisher	Triton Market Research
Published Date	July, 2022
SKU	TRTN17307653

Latin America Immunoglobulin Market 2022-2028

MARKET OUTLOOK

The Latin America immunoglobulin market is speculated to exhibit growth with a CAGR of 5.29% over the forecasting years 2022-2028, states a Triton Market Research report. Mexico, Brazil, and Rest of Latin America are assessed in the market in this region.

In Mexico, the immunoglobulin market’s growth is accelerating due to increasing government approvals, rising research & development activities, and new product launches. For instance, Mexico’s health regulator Cofepris allowed antibody treatment of Eli Lilly and Co against COVID-19 to treat comorbidities patients in emergency. This has significantly influenced other market players to tap innovation into the market through research & development activities. This is expected to bolster the growth of the studied market in the coming years.

The support from the Brazilian government and the deployment of strategic initiatives by market players have significantly aided in the development of immunoglobulin products. For instance, the Brazilian Health Regulatory Agency granted authorization for Celltrion Healthcare’s regdanvimab for emergency use. It is a monoclonal antibody treatment to treat patients with mild-to-moderate COVID-19. Likewise, in 2019, SK Plasma won a $20 million bid to supply LIV-Gamma, a human immunoglobulin, to the Brazil Ministry of Health. These factors are expected to promote the growth of the considered market over the forthcoming period.

COMPETITIVE OUTLOOK

The top players in the immunoglobulin market are China Biologic Products Inc, Octapharma AG, Kedrion Biopharma, CSL Behring, Pfizer Inc, Grifols SA, LFB Group, Sichuan Yuanda Shuyang Pharmaceutical Co Ltd, Takeda Pharmaceutical Company Limited, and Shanghai RAAS Blood Products Co Ltd.

1. Latin America Immunoglobulin Market – Summary
2. Industry Outlook: 2.1. Impact Of Covid-19 On The Immunoglobulin Market; 2.2. Key Insights; 2.2.1. Development Of New Purification Methods; 2.2.2. Increasing Preference For Personalized Medicines; 2.3. Porter’s Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Market Attractiveness Index; 2.5. Vendor Scorecard; 2.6. Key Market Strategies; 2.6.1. Product Launches & Developments; 2.6.2. Partnerships & Agreements; 2.7. Market Drivers; 2.7.1. Growth In The Geriatric Population; 2.7.2. Prevalence Of Immunodeficiency Diseases And Autoimmune Disorders; 2.7.3. Increasing Research And Development Activities; 2.8. Market Challenges; 2.8.1. High Cost Of Therapy; 2.8.2. High Risk Of Side Effects Due To The Use Of Immunoglobulin; 2.9. Market Opportunities; 2.9.1. Increasing Adoption Of Intravenous Immunoglobulin (Ivig) Treatments; 2.9.2. Growing Clinical Trials
3. Latin America Immunoglobulin Market Outlook – By Type: 3.1. Igg; 3.2. Iga; 3.3. Igm; 3.4. Ige; 3.5. Igd
4. Latin America Immunoglobulin Market Outlook – By Delivery Mode: 4.1. Intravenous; 4.2. Subcutaneous; 4.3. Intramuscular
5. Latin America Immunoglobulin Market Outlook – By Application: 5.1. Hypogamma Globulinemia; 5.2. Chronic Inflammatory Demyelinating Polyneuropathy; 5.3. Primary Immunodeficiency Diseases; 5.4. Myasthenia Gravis; 5.5. Multifocal Motor Neuropathy; 5.6. Idiopathic Thrombocytopenic Purpura (Itp); 5.7. Inflammatory Myopathies; 5.8. Specific Antibody Deficiency; 5.9. Guillain-barre Syndrome; 5.10. Other Applications
6. Latin America Immunoglobulin Market Outlook – By End-user: 6.1. Hospitals & Clinics; 6.2. Homecare
7. Latin America Immunoglobulin Market Outlook – By Sales Channel: 7.1. Hospital Pharmacy; 7.2. Specialty Pharmacy; 7.3. Other Sales Channels
8. Latin America Immunoglobulin Market – Country Outlook: 8.1. Brazil; 8.2. Mexico; 8.3. Rest Of Latin America
9. Competitive Landscape: 9.1. Biotest Ag; 9.2. China Biologic Products Inc; 9.3. Grifols Sa; 9.4. Lfb Group; 9.5. Csl Behring; 9.6. Kedrion Biopharma; 9.7. Octapharma Ag; 9.8. Takeda Pharmaceutical Company Limited; 9.9. Bio Products Laboratory; 9.10. Shanghai Raas Blood Products Co Ltd; 9.11. Pfizer Inc; 9.12. Sanquin Plasma Products Bv; 9.13. Adma Biologics; 9.14. Sichuan Yuanda Shuyang Pharmaceutical Co Ltd; 9.15. Kamada Ltd
10. Research Methodology & Scope: 10.1. Research Scope & Deliverables; 10.2. Sources Of Data; 10.3. Research Methodology
Table List: Table 1: Latin America Immunoglobulin Market, By Country Outlook, 2022-2028 (In $ Million); Table 2: Vendor Scorecard; Table 3: Latin America Immunoglobulin Market, By Type, 2022-2028 (In $ Million); Table 4: Latin America Immunoglobulin Market, By Delivery Mode, 2022-2028 (In $ Million); Table 5: Latin America Immunoglobulin Market, By Application, 2022-2028 (In $ Million); Table 6: Latin America Immunoglobulin Market, By End-user, 2022-2028 (In $ Million); Table 7: Latin America Immunoglobulin Market, By Sales Channel, 2022-2028 (In $ Million); Table 8: Latin America Immunoglobulin Market, By Country Outlook, 2022-2028 (In $ Million)
Figure List: Figure 1: Market Attractiveness Index; Figure 2: Latin America Immunoglobulin Market, By Type, 2021 & 2028 (In %); Figure 3: Latin America Immunoglobulin Market, By Igg, 2022-2028 (In $ Million); Figure 4: Latin America Immunoglobulin Market, By Iga, 2022-2028 (In $ Million); Figure 5: Latin America Immunoglobulin Market, By Igm, 2022-2028 (In $ Million); Figure 6: Latin America Immunoglobulin Market, By Ige, 2022-2028 (In $ Million); Figure 7: Latin America Immunoglobulin Market, By Igd, 2022-2028 (In $ Million); Figure 8: Latin America Immunoglobulin Market, By Delivery Mode, 2021 & 2028 (In %); Figure 9: Latin America Immunoglobulin Market, By Intravenous, 2022-2028 (In $ Million); Figure 10: Latin America Immunoglobulin Market, By Subcutaneous, 2022-2028 (In $ Million); Figure 11: Latin America Immunoglobulin Market, By Intramuscular, 2022-2028 (In $ Million); Figure 12: Latin America Immunoglobulin Market, By Application, 2021 & 2028 (In %); Figure 13: Latin America Immunoglobulin Market, By Hypogamma Globulinemia, 2022-2028 (In $ Million); Figure 14: Latin America Immunoglobulin Market, By Chronic Inflammatory Demyelinating Polyneuropathy, 2022-2028 (In $ Million); Figure 15: Latin America Immunoglobulin Market, By Primary Immunodeficiency Diseases, 2022-2028 (In $ Million); Figure 16: Latin America Immunoglobulin Market, By Myasthenia Gravis, 2022-2028 (In $ Million); Figure 17: Latin America Immunoglobulin Market, By Multifocal Motor Neuropathy, 2022-2028 (In $ Million); Figure 18: Latin America Immunoglobulin Market, By Idiopathic Thrombocytopenic Purpura (Itp), 2022-2028 (In $ Million); Figure 19: Latin America Immunoglobulin Market, By Inflammatory Myopathies, 2022-2028 (In $ Million); Figure 20: Latin America Immunoglobulin Market, By Specific Antibody Deficiency, 2022-2028 (In $ Million); Figure 21: Latin America Immunoglobulin Market, By Guillain-barre Syndrome, 2022-2028 (In $ Million); Figure 22: Latin America Immunoglobulin Market, By Other Applications, 2022-2028 (In $ Million); Figure 23: Latin America Immunoglobulin Market, By End-user, 2021 & 2028 (In %); Figure 24: Latin America Immunoglobulin Market, By Hospitals & Clinics, 2022-2028 (In $ Million); Figure 25: Latin America Immunoglobulin Market, By Homecare, 2022-2028 (In $ Million); Figure 26: Latin America Immunoglobulin Market, By Sales Channel, 2021 & 2028 (In %); Figure 27: Latin America Immunoglobulin Market, By Hospital Pharmacy, 2022-2028 (In $ Million); Figure 28: Latin America Immunoglobulin Market, By Specialty Pharmacy, 2022-2028 (In $ Million); Figure 29: Latin America Immunoglobulin Market, By Other Sales Channels, 2022-2028 (In $ Million); Figure 30: Latin America Immunoglobulin Market, Country Outlook, 2021 & 2028 (In %); Figure 31: Brazil Immunoglobulin Market 2022-2028 (In $ Million); Figure 32: Mexico Immunoglobulin Market 2022-2028 (In $ Million); Figure 33: Rest Of Latin America Immunoglobulin Market 2022-2028 (In $ Million)